EP1221945A4 - Procedes, compositions pharmaceutiques et therapeutiques destines a l'administration d'adenosine - Google Patents
Procedes, compositions pharmaceutiques et therapeutiques destines a l'administration d'adenosineInfo
- Publication number
- EP1221945A4 EP1221945A4 EP00970984A EP00970984A EP1221945A4 EP 1221945 A4 EP1221945 A4 EP 1221945A4 EP 00970984 A EP00970984 A EP 00970984A EP 00970984 A EP00970984 A EP 00970984A EP 1221945 A4 EP1221945 A4 EP 1221945A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- pharmaceutical
- methods
- therapeutic compositions
- administering adenosine
- adenosine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- General Chemical & Material Sciences (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16063499P | 1999-10-20 | 1999-10-20 | |
US160634P | 1999-10-20 | ||
PCT/US2000/028769 WO2001028528A1 (fr) | 1999-10-20 | 2000-10-18 | Procedes, compositions pharmaceutiques et therapeutiques destines a l'administration d'adenosine |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1221945A1 EP1221945A1 (fr) | 2002-07-17 |
EP1221945A4 true EP1221945A4 (fr) | 2005-06-15 |
Family
ID=22577721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00970984A Withdrawn EP1221945A4 (fr) | 1999-10-20 | 2000-10-18 | Procedes, compositions pharmaceutiques et therapeutiques destines a l'administration d'adenosine |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1221945A4 (fr) |
AU (1) | AU8028600A (fr) |
WO (1) | WO2001028528A1 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1274444B1 (fr) | 2000-03-16 | 2013-05-15 | THE McLEAN HOSPITAL CORPORATION | Cdp-choline et uridine pour le traitement de l'abus d'alcool |
US20030069203A1 (en) * | 2001-06-04 | 2003-04-10 | Lee Steve S. | Method for increasing human performance by reducing muscle fatigue and recovery time through oral administration of adenosine triphosphate |
US7629329B2 (en) * | 2001-06-04 | 2009-12-08 | Tsi Health Sciences, Inc. | Method for increasing muscle mass and strength through administration of adenosine triphosphate |
US7947661B2 (en) | 2004-08-11 | 2011-05-24 | The Mclean Hospital Corporation | Compounds for the treatment of marihuana dependence, withdrawal, and usage |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0344795A1 (fr) * | 1988-06-03 | 1989-12-06 | Senju Pharmaceutical Co., Ltd. | Composition pharmaceutique stabilisée et procédé pour la préparer |
EP0348688A1 (fr) * | 1988-06-03 | 1990-01-03 | Senju Pharmaceutical Co., Ltd. | Préparation pharmaceutique solide et procédé d'obtention de celle-ci |
EP0352477A2 (fr) * | 1988-07-25 | 1990-01-31 | Eliezer Rapaport | Utilisation de l'adénosine-5'-phosphate dans le traitement de cancer cachexia |
WO1993021783A1 (fr) * | 1992-05-06 | 1993-11-11 | The Penn State Research Foundation | Procedes de traitement de l'obesite au moyen de composes apparentes a la purine |
US5547942A (en) * | 1994-01-04 | 1996-08-20 | Rapaport; Eliezer | Method of treatment of diabetes mellitus by administration of adenosine 5'-t |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5900407A (en) * | 1997-02-06 | 1999-05-04 | Inspire Pharmaceuticals, Inc. | Method of treating dry eye disease with uridine triphosphates and related compounds |
-
2000
- 2000-10-18 EP EP00970984A patent/EP1221945A4/fr not_active Withdrawn
- 2000-10-18 AU AU80286/00A patent/AU8028600A/en not_active Abandoned
- 2000-10-18 WO PCT/US2000/028769 patent/WO2001028528A1/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0344795A1 (fr) * | 1988-06-03 | 1989-12-06 | Senju Pharmaceutical Co., Ltd. | Composition pharmaceutique stabilisée et procédé pour la préparer |
EP0348688A1 (fr) * | 1988-06-03 | 1990-01-03 | Senju Pharmaceutical Co., Ltd. | Préparation pharmaceutique solide et procédé d'obtention de celle-ci |
EP0352477A2 (fr) * | 1988-07-25 | 1990-01-31 | Eliezer Rapaport | Utilisation de l'adénosine-5'-phosphate dans le traitement de cancer cachexia |
WO1993021783A1 (fr) * | 1992-05-06 | 1993-11-11 | The Penn State Research Foundation | Procedes de traitement de l'obesite au moyen de composes apparentes a la purine |
US5547942A (en) * | 1994-01-04 | 1996-08-20 | Rapaport; Eliezer | Method of treatment of diabetes mellitus by administration of adenosine 5'-t |
Non-Patent Citations (2)
Title |
---|
KAARTINEN J M ET AL: "ATTENUATED ADENOSINE-SENSITIVITY AND DECREASED ADENOSINE-RECEPTOR NUMBER IN ADIPOCYTE PLASMA MEMBRANES IN HUMAN OBESITY", BIOCHEMICAL JOURNAL, vol. 279, no. 1, 1991, pages 17 - 22, XP009046533, ISSN: 0264-6021 * |
See also references of WO0128528A1 * |
Also Published As
Publication number | Publication date |
---|---|
AU8028600A (en) | 2001-04-30 |
EP1221945A1 (fr) | 2002-07-17 |
WO2001028528A1 (fr) | 2001-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CZ20012028A3 (cs) | Nové N-substituované 2-kyanopyrrolidiny, farmaceutický prostředek, který je obsahuje a jejich použití jako léčivo | |
HUP0204515A3 (en) | 4-aminopiperidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
IL149224A0 (en) | Hydrogen-driven drug dosage form | |
HUP0300618A3 (en) | Adamantana derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
IL150346A0 (en) | Benzazole derivatives, their preparation and pharmaceutical compositions containing them | |
IL145150A0 (en) | Pyridopyranoazepine derivatives, preparation and therapeutic use | |
AU9018898A (en) | Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments | |
HUP0301333A3 (en) | Pharmaceutical superdisintegrant, process for its preparation and its use | |
ZA200308221B (en) | Pharmaceutical compositions for oral and topical administration. | |
HRPK20010706B1 (en) | Tolperison-containing, pharmaceutical preparation for oral administration | |
HUP0201649A2 (en) | Purine derivatives, preparation method and pharmaceutical compositions containing same | |
HUP0201315A3 (en) | 4-phenyl-pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
HUP0203627A3 (en) | N-guanidinoalkylamides, their preparation, their use, and pharmaceutical compositions comprising them | |
HUP0500958A3 (en) | 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them, therapeutic use thereof and pharmaceutical compositions containing them | |
HUP0201797A3 (en) | 3-amino-2-benzyl-1-phenyl-propane derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
EP1221945A4 (fr) | Procedes, compositions pharmaceutiques et therapeutiques destines a l'administration d'adenosine | |
IL158587A0 (en) | Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof | |
HUP0203468A3 (en) | Betha-d-5-thioxylose derivatives, preparation method and therapeutic use thereof | |
GB9902227D0 (en) | Pharmaceutical composition for topical administration | |
PL325509A1 (en) | Therapeutic agent for oral administration | |
EP1188440A4 (fr) | Composition medicinale pour administration par voie orale | |
IL149653A0 (en) | 2-arylquinoline derivatives, preparation and therapeutic use thereof | |
SI1161434T1 (en) | Pyridopyranoazepine derivatives, preparation and therapeutic use | |
SI1183256T1 (sl) | Derivati purina, postopek za njihovo pripravo in farmacevtski sestavki,ki jih vsebujejo | |
IL128582A0 (en) | Pharmaceutical dosage form |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20020423 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20050503 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 61K 31/7076 B Ipc: 7A 61K 9/28 A Ipc: 7A 61P 3/04 B |
|
17Q | First examination report despatched |
Effective date: 20050728 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20100301 |